EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 33 (2026) Parasite, 33 (2026) 36 References
Open Access
Issue
Parasite
Volume 33, 2026
Article Number 36
Number of page(s) 9
DOI https://doi.org/10.1051/parasite/2026035
Published online 22 June 2026
  1. Bamba S, Séré A, Nikiéma R, Halidou T, Thiéba B, Dao B, Guiguemdé RT. 2013. Intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnant women: efficacy and compliance in two urban hospitals in Burkina Faso. Pan African Medical Journal, 14, 105. [Google Scholar]
  2. Braunm V, Rempis E, Schnack A, Decker S, Rubaihayo J, Tumwesigye NM, Theuring S, Harms G, Busingye P, Mockenhaupt FP. 2015. Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda. Malaria Journal, 14, 372. [Google Scholar]
  3. Cissé M, Awandare GA, Soulama A, Tinto H, Hayette MP, Guiguemdé RT. 2017. Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of pfdhfr mutations in Bobo-Dioulasso, Burkina Faso. Malaria Journal, 16, 38. [Google Scholar]
  4. Cissé M, Sirima C, Gomgnimbou MK, Traoré IT, Drabo H, Sanou AQ, Silga EW, Soulama A, Kornu VE, Anshah F, Djibougou AD, Diallo I, Zida A, Sangaré I, Bamba S, Aniweh Y, Zongo I, Awandare GA. 2025. Diagnostic performance of NxTek TM Eliminate Malaria Pf test for the detection of Plasmodium falciparum infection in pregnant women from Bobo-Dioulasso, Burkina Faso. African Journal of Parasitology, Mycology and Entomology, 3, 3. [Google Scholar]
  5. Coulibaly SO, Kayentao K, Taylor S, Guirou EA, Khairallah C, Guindo N, Djimde M, Bationo R, Soulama A, Dabira E, Barry B, Niangaly M, Diakite H, Konate S, Keita M, Traore B, Meshnich SR, Magnussen P, Doumbo OK, ter Kuile FO. 2014. Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina Faso and Mali: 42-day in vivo follow-up study. Malaria Journal, 13, 41. [Google Scholar]
  6. Das JK, Lakhani S, Rahman AR, Siddiqui F, Padhani ZA, Rashid Z, Mahmud O, Naqvi SK, Naseem HA, Jehanzeb H, Kumar S, Beg MA. 2024. Malaria in pregnancy: meta-analyses of prevalence and associated complications. Epidemiology and Infection, 152, e39. [Google Scholar]
  7. Diouf MP, Oboh MA, Manga IA, Kande S, Colle Lo A, Sall FB, Seck A, Faye B, Merle CS, Amambua-Ngwa A, Miligan P, Ndiaye JLA. 2024. Monitoring Plasmodium falciparum drug resistance markers in pregnant women attending antenatal clinics in Senegal. African Journal of Parasitology, Mycology and Entomology, 2, 13. [Google Scholar]
  8. Djontu JC, Baina MT, Ntabi JDM, Lissom A, Umuhoza DM, Doulamo NVA, Vouvoungui CJ, Boumpoutou RK, Mouanga AM, Nguimbi E, Ntoumi F. 2024. Profile of molecular markers of sulfadoxine-pyrimethamine-resistant Plasmodium falciparum in individuals living in southern area of Brazzaville, Republic of Congo. International Journal for Parasitology: Drugs and Drug Resistance, 26, 100569. [Google Scholar]
  9. Dosoo KD, Bailey JA, Asante KP, Oppong BF, Niaré K, Opoku-Mensah J, Owusu-Agyei S, Greenwood B, Chandramohan D. 2022. The prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine among pregnant women at first antenatal clinic attendance and delivery in the forest-savannah area of Ghana. PLoS One, 17, e0271489. [Google Scholar]
  10. Duraisingh MT, Curtis J, Warhurst DC. 1998. Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Experimental Parasitology, 89, 1–8. [Google Scholar]
  11. Gies S, Coulibaly SO, Ouattara FT, D’Alessandro U. 2009. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso. Tropical Medicine and International Health, 14, 174–182. [Google Scholar]
  12. Hofmann N, Mwingira F, Shekalaghe S, Robinson LJ, Mueller I, Felger I. 2015. Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets. PLoS Medicine, 12, e1001788. [Google Scholar]
  13. Hyde JE. 2008. Antifolate resistance in Africa and the 164-dollar question. Transactions of the Royal Society of Tropical Medicine and Hygiene, 102, 301–303. [Google Scholar]
  14. Juma DW, Muiruri P, Yuhas K, John-Stewart G, Ottichilo R, Waitumbi J, Singa B, Polyak C, Kamau E. 2019. The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis. PLoS Neglected Tropical Diseases, 13, e0007223. [Google Scholar]
  15. Leke RFG, Bioga JD, Zhou J, Fouda GG, Leke RJI, Tchinda V, Megnekou R, Fogako J, Sama G, Gwanmesia P, Bomback G, Nama C, Diouf A, Bobbili N, Taylor DW. 2010. Longitudinal studies of Plasmodium falciparum malaria in pregnant women living in a rural Cameroonian village with high perennial transmission. American Journal of Tropical Medicine and Hygiene, 83, 996–1004. [Google Scholar]
  16. Menéndez C, Serra-Casas E, Scahill MD, Sanz S, Nhabomba A, Bardají A, Sigauque B, Cisteró P, Mandomando I, Dobaño C, Alonso PL, Mayor A. 2011. HIV and placental infection modulate the appearance of drug-resistant Plasmodium falciparum in pregnant women who receive intermittent preventive treatment. Clinical Infectious Diseases, 52, 41–48. [Google Scholar]
  17. Ministère de la santé. 2014. Directives nationales pour la prise en charge du paludisme dans les formations sanitaires du Burkina Faso. Révision de mars 2014. Ouagadougou: Ministère de la Santé du Burkina Faso. [Google Scholar]
  18. Ministère de la santé. 2021. Directives nationales de prise en charge du paludisme au Burkina Faso. Ouagadougou: Ministère de la Santé du Burkina Faso. [Google Scholar]
  19. Ministère de la santé. 2025. Annuaire Statistique 2024. Ouagadougou: Ministère de la Santé du Burkina Faso. [Google Scholar]
  20. Minwuyelet A, Yewhalaw D, Siferih M, Atenafu G. 2025. Current update on malaria in pregnancy: a systematic review. Tropical Diseases, Travel Medicine and Vaccines, 11, 14. [Google Scholar]
  21. Mockenhaupt FP, Eggelte TA, Böhme T, Thompson WN, Bienzle U. 2001. Plasmodium falciparum dihydrofolate reductase alleles and pyrimethamine use in pregnant Ghanaian women. American Journal of Tropical Medicine and Hygiene, 65, 21–26. [Google Scholar]
  22. Ouédraogo LT, Somé IT, Diarra M, Guissou IP. 2008. Automédication dans le traitement de l’accès palustre : étude auprès de clients d’officines pharmaceutiques privées de la ville de Ouagadougou, Burkina Faso. Bulletin de la Société de Pathologie Exotique, 101, 124–127. [Google Scholar]
  23. Peterson DS, Walliker D, Wellems TE. 1988. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proceedings of the National Academy of Sciences USA, 85, 9114–9118. [Google Scholar]
  24. Roh ME, Zongo I, Haro A, Huang L, Somé AF, Yerbanga RS, Conrad MD, Wallender E, Legac J, Aweeka F, Ouédraogo JB, Rosenthal PJ. 2023. Seasonal malaria chemoprevention drug levels and drug resistance markers in children with or without malaria in Burkina Faso. Journal of Infectious Diseases, 228, 926–935. [Google Scholar]
  25. Ruizendaal E, Tahita MC, Geskus RB, Versteeg I, Scott S, D’Alessandro U, Lompo P, Derra K, Traore- Coulibaly M, de Jong MD, Schallig HDFH, Tinto H, Mens PF. 2017. Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso. Malaria Journal, 16, 179. [Google Scholar]
  26. Sawadogo H, Soulama I, Zida A, Zongo C, Sawadogo PM, Guiguemdé KT, Nikiema S, Badoum SE, Sawadogo S, Tou A, Sombié S, Tchekounou C, Sermé SS, Ouédraogo-Traoré R, Guiguemdé TR, Savadogo A. 2023. Plasmodium falciparum genetic diversity and resistance genotype profile in infected placental samples collected after delivery in Ouagadougou. Infection and Drug Resistance, 16, 6673–6680. [Google Scholar]
  27. Schleiermacher D, Rogier C, Spiegel A, Tall A, Trape JF, Mercereau-Puijalon O. 2001. Increased multiplicity of Plasmodium falciparum infections during pregnancy. American Journal of Tropical Medicine and Hygiene, 64, 303–309. [Google Scholar]
  28. Tarama WC, Soré H, Siribié M, Débé S, Kinda R, Ganou A, Nonkani WG, Tiendrebeogo F, Bantango W, Yira K, Sagnon A, Ilboudo S, Hien EY, Wandaogo MG, Sagnon N, Traoré Y, Ménard D, Gansané A. 2023. Plasmodium falciparum drug resistance-associated mutations in isolates from children living in endemic areas of Burkina Faso. Malaria Journal, 22, 213. [Google Scholar]
  29. Triglia T, Menting JG, Wilson C, Cowman AF. 1997. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proceedings of the National Academy of Sciences USA, 94, 13944–13949. [Google Scholar]
  30. Van Eijk AM, Stepniewska K, Khairallah C, Rodriguez E, Ahn J, Gutman JR. 2025. The impact of sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive treatment for malaria in pregnancy in Africa. Lancet Infectious Diseases, 25, 1336–1346. [Google Scholar]
  31. World Health Organization. 2011. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva: World Health Organization. [Google Scholar]
  32. World Health Organization. 2016. Malaria microscopy quality assurance manual-version 2. Geneva: World Health Organization. [Google Scholar]
  33. World Health Organization. 2025. World malaria report 2025. Geneva: World Health Organization. [Google Scholar]
  34. World Health Organization. 2025. WHO guidelines for malaria. Geneva: World Health Organization. [Google Scholar]
  35. Zida A, Tchekounou C, Soulama I, Zongo C, Sombié S, Nikiema S, Yanogo NJ, Sawadogo S, Kaboré FCA, Zoure OAZD, Sawadogo H, Sawadogo PM, Tibiri YNG, Guiguemdé KT, Ily RP, Traoré RO, Ouedraogo Y, Savadogo A. 2024. Characterization of Plasmodium falciparum resistance genes to common antimalarial drugs in semi-urban areas of Burkina Faso. Acta Parasitologica, 69, 910–921. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.